Navigation Links
Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status
Date:2/23/2013

ung health portfolio is designed to help address the challenges people living with a lung disease face every day. Leveraging the company's cutting edge science and leadership in chronic obstructive pulmonary disease (COPD), BI is researching new treatment approaches where needs persist. It is the company's goal to make a difference in the lives of patients with COPD, asthma, lung cancer, idiopathic pulmonary fibrosis and other respiratory diseases.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. Subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act in a socially responsible manner. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5 percent of its net sales.

For more information, please visit http://us.boehringer-ingelheim.com
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... A pharmaceutical executive in the market research ... he wanted the research and consulting firm to explore: ... for secondary research) to maximize efficiency and maintain a ... , Automation of market research processes for efficient ... to implement and manage those automated systems ...
(Date:9/19/2014)... "Copay coupons," a drug manufacturer ... drugs among patients with prescription drug coverage, may now be ... report  from the Department of Health and ... anti-kickback laws prohibit suppliers from offering side-payments to ... the federal government. The report ...
(Date:9/19/2014)... DALLAS , Sept. 19, 2014 /PRNewswire-iReach/ ... Chinese Oxybutynin Hydrochloride Industry, 2009-2019 is a ... and Chinese Oxybutynin Hydrochloride industry. The report ... Hydrochloride including its classification, application and manufacturing ... China,s top manufacturers of Oxybutynin Hydrochloride listing ...
Breaking Medicine Technology:In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5
(Date:9/20/2014)... Recently, UWDress.com, a professional company of women’s ... its newly announced evening cocktail dresses . As ... occasion outfits are very popular among worldwide customers. Now, ... savings (up to 65 percent off). , All ... special occasion outfits for the global clients. The company ...
(Date:9/20/2014)... GA (PRWEB) September 20, 2014 David ... 20, 2014. The first poster looked at the clinical ... cardiac cycle for calculating diastolic function. In conjunction with ... end-stage renal disease and normal LVEF by echo (>50%). ... stress protocol, and standard SPECT. Emory Toolbox 4.0 ...
(Date:9/20/2014)... NY (PRWEB) September 20, 2014 Ticket ... Grande concert tickets . This popular ticket exchange is ... , The 2015 schedule of tours is beginning ... have already announced their plans to hit the road, including ... Raton, Fla., announced the “Honeymoon Tour,” which will take her ...
(Date:9/20/2014)... 2014 The print component of ... of the Calgary Herald, with a circulation of ... 270,000. The digital component is distributed nationally through ... network of top news sites and partner outlets. ... visit http://www.worklifebalanceinfo.ca . , The publication features ...
(Date:9/20/2014)... The festival season is coming soon. The high-end ... luxurious cocktail dresses . A lot of sophisticated women ... launch a new promotion for its high quality clothes. Now, ... price, from 20 to 71 percent off. , The ... They are provided in many fashionable colors. Mary, the company’s ...
Breaking Medicine News(10 mins):Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2
... matter, researchers say, , FRIDAY, Feb. 12 (HealthDay News) -- One ... as part of the measles, mumps and rubella (MMR) vaccine -- ... new findings come about a week after The Lancet ... autism risk. At the time, the Lancet study alarmed ...
... impurities is a myth, expert says, , FRIDAY, Feb. 12 ... practices that promise to "detoxify" the body through various means, ... some may be relatively harmless, the desire to detox was ... died and several were made seriously ill during a pricey ...
... ... the CoSign® digital signature solution, to present the use of digital signatures in clinical ... conference. , ... Francisco, CA (PRWEB) February 12, 2010 -- ARX, the leading provider of digital signature ...
... , - Payment to Bioniche of ... ON , Feb. 12 /PRNewswire-FirstCall/ - Bioniche ... Canadian biopharmaceutical company, today announced that it has met ... agreement with Endo Pharmaceuticals ( ENDP) for exclusive rights ...
... , , WASHINGTON , ... a symposium exploring the future of cancer research on Feb. ... by the Ruesch Center for the Cure of Gastrointestinal Cancers, the ... & the Cure for Cancer, " will offer a focus on ...
... , CHESTERFIELD, Mo. , ... arm of Reliv International, Inc., is donating $450,000 ...   , The donation includes more than 3,000 cases of ... of essential vitamins, minerals and micronutrients designed to strengthen children,s ...
Cached Medicine News:Health News:Another Study Refutes Vaccination-Autism Link 2Health News:Sweat Lodges, Steam Rooms Aren't for Detox 2Health News:Sweat Lodges, Steam Rooms Aren't for Detox 3Health News:Sweat Lodges, Steam Rooms Aren't for Detox 4Health News:Digital Signatures Presented at Electronic Document Management Conference 2Health News:Bioniche Achieves Two Additional Milestones Under Licensing Agreement; Endo Takes up Global Rights 2Health News:Bioniche Achieves Two Additional Milestones Under Licensing Agreement; Endo Takes up Global Rights 3Health News:GUMC's Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine 2Health News:GUMC's Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine 3Health News:Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts 2Health News:Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts 3
This table has adjustable height, square post and adjustable leg. Includes clamps, and standard 1" (2.5 cm) pad....
Built-in accessory rail clamps quickly mount to any standard O.R. table or stretcher. The leg, available in single post or double tee adjusts with a simple twist. Optional armrests are available. Wal...
... This ultralight and ultra versatile model ... twist will adjust the height of ... as a single post, or double ... armrests for physician comfort and stability. ...
The DHS Basic Set is available with either self-tapping or non-self-tapping screws. Either instrument set provides complete instrumentation in one graphic case for use with the Universal Implant Set,...
Medicine Products: